Morris Laster

Dr. Morris Laster is a healthcare executive and entrepreneur with close to 30 years of experience in the biopharmaceutical industry. His expertise lies in the identification, development, management and financing of advanced biomedical drugs and technologies. Dr. Laster is the CEO of Clil Medical Ltd a biomedical consultancy company. He is also the Medical Venture Partner at OurCrowd (www.ourcrowd.com) where he has led 28 investments. He is an OurCrowd Board member of HiL, BrainQ and Dreamed. Additionally, he serves as the Chairman of Oncohost as well as a board member at BiondVax (NASDAQ:BVXV). He has founded 6 companies that have gone public in the US, UK and Israel. He was a co-founder and CEO of Kitov Pharmaceuticals that has FDA approval for its drug Consensi. Previously, (2003-2009) he was the founding CEO of BioLineRx Ltd. (TASE:BLRX). From 1997-2002 he was the Chairman and CEO of Keryx Biopharmaceuticals (NASDAQ:KERX). He began his career as a VP of medical venture capital at Paramount Capital in NYC. Dr. Laster received his MD from Downstate Medical Center, Brooklyn, NY in 1990 and a BS in Biology from SUNY Albany.